NSECertificate under SEBI (Depositories and Participants) Regulations, 20182 Jul 2026 · 2 Jul 2026, 04:28 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Aurobindo Pharma Limited · AUROPHARMA
✦ AI Summary
Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, certifying the details of securities dematerialized/rematerialized during the quarter ended June 30, 2026, have been furnished to all the stock exchanges where the shares of the Company are listed.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
AUROPHARMA_02072026162744_LtrToSEsReg74Compliance30062026.pdf
View document text
July 2, 2026
To To
Listing Department, The Corporate Relations Department
NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED
Exchange Plaza, Phiroz Jeejeebhoy Towers,
Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street,
MUMBAI -400 051 MUMBAI -400 001
Company Code No. AUROPHARMA Company Code No. 524804
Dear Sir / Madam,
Sub: Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
This is to certify that the details of securities dematerialized / rematerialized during the quarter ended June 30,
2026, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been
furnished to all the stock exchanges where the shares of the Company are listed. The letters confirming this from
our RTA - M/s. KFin Technologies Limited dated July 1, 2026, are enclosed for your reference. Further, the
certificates of securities which were dematerialized are listed on the Stock Exchanges where earlier issued
securities of the Company were listed.
Please take the information on record.
Thanking you,
Yours faithfully,
For AUROBINDO PHARMA LIMITED
B. Adi Reddy
Company Secretary
Encl: as above.
Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India.
Tel: +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044.
Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana, India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833
Email: info@aurobindo.com Website: www.aurobindo.com
KFIN/APLN/NSDL/74(5) E/1
Date: 01‐07‐2026
NATIONAL SECURITIES DEPOSITORY LIMITED
TRADE WORLD 4TH FLOOR
KAMALA MILLS COMPOUND
SENAPATI BAPAT MARG
LOWER PAREL
MUMBAI ‐ 400 013
Dear Sir(s),
Sub: Certificate under Regulation 74(5) for the quarter ended June 30,2026
We as Registrar to an Issue and Share Transfer Agent of the AUROBINDO PHARMA LIMITED, certify
that the details of securities dematerialized/rematerialized during the aforesaid period, as required
under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been furnished
to all the Stock Exchanges where the shares of the company are listed.
Thanking You
Yours faithfully,
for KFIN TECHNOLOGIES LIMITED
C SHOBHA ANAND
VICE PRESIDENT
CC TO:
AUROBINDO PHARMA LIMITED
GALAXY, FLOOR 22‐24, PLOT NO. 1, SURVEY
HYDERABAD KNOWLEDGE CITY, RAIDURG PANMAK
HYDERABAD
RANGA REDDY DISTRICT
500032
KFIN/APLN/CDSL/74(5) E/1
Date: 01‐07‐2026
CENTRAL DEPOSITORY SERVICES (INDIA) LIMITED
REGD OFF: MARATHON FUTUREX, A WING
25TH FLOOR
NM JOSHI MARG
LOWER PAREL (EAST)
MUMBAI ‐ 400 023
Dear Sir(s),
Sub: Certificate under Regulation 74(5) for the quarter ended June 30,2026
We as Registrar to an Issue and Share Transfer Agent of the AUROBINDO PHARMA LIMITED, certify
that the details of securities dematerialized/rematerialized during the aforesaid period, as required
under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been furnished
to all the Stock Exchanges where the shares of the company are listed.
Thanking You
Yours faithfully,
for KFIN TECHNOLOGIES LIMITED
C SHOBHA ANAND
VICE PRESIDENT
CC TO:
AUROBINDO PHARMA LIMITED
GALAXY, FLOOR 22‐24, PLOT NO. 1, SURVEY
HYDERABAD KNOWLEDGE CITY, RAIDURG PANMAK
HYDERABAD
RANGA REDDY DISTRICT
500032